Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …

Nuclear medicine is composed of two complementary areas, imaging and therapy. Positron
emission tomography (PET) and single-photon imaging, including single-photon emission …

89Zr is an emerging radionuclide that plays an essential role in immuno-positron emission
tomography (PET) imaging. The long half-life of 89Zr (t1/2= 3.3 days) is favorable for …

Diagnostic molecular images, obtained by positron emission tomography (PET), have
successfully functioned as sensitive tools for detecting and monitoring the treatment of …

Abstract Zirconium-89 (89 Zr) is an emerging radionuclide for positron emission tomography
(PET), with nuclear properties suitable for imaging slow biological processes in cellular …

Recently, the demand for hybrid PET/MRI imaging techniques has increased significantly,
which has sparked the investigation into new ways to simultaneously track multiple …

A process for the production of tens to hundreds of GBq amounts of zirconium-88 (88Zr)
using proton beams on yttrium was developed. For this purpose, yttrium metal targets (≈ 20 …

Increased interest in radiometals for nuclear medicine and imaging can be hampered by
radionuclide supply. 89 Zr for example, is a PET imaging nuclide for which no radionuclide …

We report two bifunctional chelators, DFO-Cys and DFO-CBT, to label biovectors with
zirconium-89 according to the 2-cyanobenzothiazole/1, 2-aminothiol cycloaddition. Their …

The presence of radioactive impurities in radionuclides that are used for medical
applications may adversely affect the quality of diagnostic images and increase radiation …